<p>(<b>A–C</b>) incidence of peritoneal carcinomatosis, weight of metastatic lesions (mean + SEM) and incidence of ascites fluid in groups of 5–7 mice. Statistically significant differences: panel <b>B</b>, p = 0.007 at Student's <i>t</i> test; panel <b>C</b>, p = 0.027 at Fisher's exact test. (<b>D</b>) control mouse, treated with vehicle (PBS) alone, showing multiple i.p. masses (green arrows); (<b>E</b>) tumor-free mouse treated with R-LM249; (<b>F</b>) distribution of R-LM249 in a mouse bearing multiple i.p. tumors shows that the virus selectively populates and replicates in the HER-2+ masses (green fluorescence: virally-encoded EGFP; yellow-brown florescence: autofluorescence of mouse fur and visceral organs).</p
<p>Mice with peritoneal carcinomatosis (n = 12) received i.p injection of wtPV-H1, rPVH1-GFP or rPVH...
<p>(A) Schedule of the treatments. The HER2-transgenic/tolerant mice, implanted with HER2-LLC1 cells...
<p>A new group of mice treated with R-LM113 or R-115 from d 10 after tumor implantation (same treatm...
<p>(<b>A</b>) and (<b>B</b>), tumor volumes. R-LM249 was administered intratumorally at the indicate...
<p>Red arrows below <i>x</i>-axis mark the days in which groups of 5 mice received weekly i.p. treat...
Oncolytic viruses aim to specifically kill tumor cells. A major challenge is the effective targeting...
<div><p>Oncolytic viruses aim to specifically kill tumor cells. A major challenge is the effective t...
<p>(A) Treatment of 8-week old female athymic nude mice with IL12-SS1 (Fv) after intraperitoneal inj...
<p>Mice injected i.p. with SKOV3 cells underwent 20(S)-Rg3 treatment for 30 days. (A) The body weigh...
<p>R-LM249 was administered i.p. at 10<sup>8</sup> pfu dose (4 weekly injections) to groups of 9–10 ...
International audiencePURPOSE: Ovarian peritoneal carcinomatosis is a pathology for which effective ...
<p>ID8ip2Luc ovarian cancer cells were injected IP into C57BL/6 (WT) or LPP1 KO mice. <b>(A)</b> Mic...
Oncolytic viruses aim to specifically kill tumor cells. A major challenge is the effective targeting...
BackgroundPeritoneal carcinomatosis is a hallmark of advanced peritoneal tumor progression, particul...
Since the discovery of the nude mouse more than 40 years ago, investigators have attempted to mode...
<p>Mice with peritoneal carcinomatosis (n = 12) received i.p injection of wtPV-H1, rPVH1-GFP or rPVH...
<p>(A) Schedule of the treatments. The HER2-transgenic/tolerant mice, implanted with HER2-LLC1 cells...
<p>A new group of mice treated with R-LM113 or R-115 from d 10 after tumor implantation (same treatm...
<p>(<b>A</b>) and (<b>B</b>), tumor volumes. R-LM249 was administered intratumorally at the indicate...
<p>Red arrows below <i>x</i>-axis mark the days in which groups of 5 mice received weekly i.p. treat...
Oncolytic viruses aim to specifically kill tumor cells. A major challenge is the effective targeting...
<div><p>Oncolytic viruses aim to specifically kill tumor cells. A major challenge is the effective t...
<p>(A) Treatment of 8-week old female athymic nude mice with IL12-SS1 (Fv) after intraperitoneal inj...
<p>Mice injected i.p. with SKOV3 cells underwent 20(S)-Rg3 treatment for 30 days. (A) The body weigh...
<p>R-LM249 was administered i.p. at 10<sup>8</sup> pfu dose (4 weekly injections) to groups of 9–10 ...
International audiencePURPOSE: Ovarian peritoneal carcinomatosis is a pathology for which effective ...
<p>ID8ip2Luc ovarian cancer cells were injected IP into C57BL/6 (WT) or LPP1 KO mice. <b>(A)</b> Mic...
Oncolytic viruses aim to specifically kill tumor cells. A major challenge is the effective targeting...
BackgroundPeritoneal carcinomatosis is a hallmark of advanced peritoneal tumor progression, particul...
Since the discovery of the nude mouse more than 40 years ago, investigators have attempted to mode...
<p>Mice with peritoneal carcinomatosis (n = 12) received i.p injection of wtPV-H1, rPVH1-GFP or rPVH...
<p>(A) Schedule of the treatments. The HER2-transgenic/tolerant mice, implanted with HER2-LLC1 cells...
<p>A new group of mice treated with R-LM113 or R-115 from d 10 after tumor implantation (same treatm...